EU OKs wider use of Roche's Avastin

Swiss drugmaker Roche Holding today announced that the EU has permitted the use of its cancer treatment Avastin with other chemotherapy drugs, including its oral treatment Xeloda. The approval covers the drug's use for initial and later treatment in metastatic colorectal cancer patients.

View Full Article in:

Wall Street Journal (free content), The · Guardian (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director of Litigation
Center for Science in the Public Interest
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC